Researchers indicated that while current vaccines for SARS-CoV-2 and influenza are generally safe and effective, there is still considerable room for improvement.

Novavax's fourth-quarter loss narrowed on Thursday, helped by reduced selling and administrative expenses of COVID-19 ...

Novavax on Thursday posted a narrower fourth-quarter loss and said it expects its licensing deal with French drugmaker Sanofi ...

Cornell researchers have developed a new vaccine platform that could provide more robust, longer-lasting protection from both ...

Children vaccinated against COVID-19 were more than 50% less likely to develop at least one long COVID symptom compared with ...

The current COVID-19 vaccine is 33% effective at preventing emergency department or urgent care visits among adults of all ages. It also is 45% to 46% effective at preventing hospitalizations in older ...

The new vaccine addresses significant limitations of existing COVID-19 and flu vaccines. While mRNA COVID-19 vaccines require ...

Iowa lawmakers advanced a bill Monday banning the administration of mRNA vaccines. The bill, Senate File 360, would outlaw ...

Senators heard testimony from Iowans Monday, over a bill that would prohibit anyone in Iowa from administering gene-based vaccines.Right now, the only gene base ...

Bagdasarian also recommends ensuring kids take in a lot of fluids and said over the counter medicines like Tylenol and ...

Cornell University researchers have developed a new vaccine platform that could provide more robust, longer-lasting protection from both COVID-19 and influenza, and broader immunity to different flu ...

Senate Republicans seem to be cruising toward confirming as the director of the National Institutes of Health an academic who ...